International Journal of Molecular Sciences Article Efficacy and Safety of Human Serum Albumin–Cisplatin Complex in U87MG Xenograft Mouse Models Cho Rong Park 1,2,3, Hyo Young Kim 1,2, Myung Geun Song 1,2,4,*, Yun-Sang Lee 1,5, Hyewon Youn 1,2,6, June-Key Chung 1,2,3,4, Gi Jeong Cheon 1,2,4,5,7 and Keon Wook Kang 1,2,3,4,5,6,8,* 1 Department of Nuclear Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea; siofl
[email protected] (C.R.P.);
[email protected] (H.Y.K.);
[email protected] (Y.-S.L.);
[email protected] (H.Y.);
[email protected] (J.-K.C.);
[email protected] (G.J.C.) 2 Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul 03080, Korea 3 Department of Biomedical Sciences, Seoul National University Graduate School, Biomedical Science Building, Seoul 03080, Korea 4 Biomedical Research Institute, Seoul National University Hospital, Seoul 03080, Korea 5 Radiation Research Institute, Seoul National University College of Medicine, Seoul 03080, Korea 6 Cancer Imaging Center, Seoul National University Hospital, Seoul 03080, Korea 7 Institute on Aging, Seoul National University, Seoul 08826, Korea 8 Bio-MAX Institute, Seoul National University, Seoul 08826, Korea * Correspondence:
[email protected] (M.G.S.);
[email protected] (K.W.K.); Tel.: +82-2-2072-2803 (K.W.K.) Received: 18 September 2020; Accepted: 22 October 2020; Published: 26 October 2020 Abstract: Cisplatin (cis-diamminedichloroplatinum (II), CDDP) is a chemotherapeutic drug widely used against many solid tumors.